MRD / Regn No. : 324 Date : 18/06/2026
Patient Name : Purabi Das Age & Gender : 64 Yrs. / Female
Contact No. : 9735577395 UHID :
Ht / Wt / BMI : 149 / 75 / 33.78 BP S / BP D : 111 / 66
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (31/Oct/2010) | HYPERTENSION (31/Oct/2022) |
Salient Investigations : POTASSIUM: 4.01 | CREATININE: 0.86 | EGFR EGLOMERULAR FILTRATION RATE: 71.12 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 117 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 7.9 % | MICROALBUMIN CREATININE RATIO: 49 mcg/mg
S# Generic (Trade) Name Route Dosage Usage Duration
1 TELMISARTAN 80 MG + AMLODIPINE 5 MG
TELDAY AM 80/5 MG 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
2 TABLET ROSUVASTATIN 10 MG
STATEZE R 		PO 0-0-1 BEFORE DINNER
3 GLICLAZIDE 80 MG + METFORMIN 500 MG
CYBLEX M 80 MG 		PO 1-0-1 BEFORE BREAKFAST AND DINNER
 TILL NEXT VISIT
4 INJECTION SEMAGLUTIDE 0.25 MG
NOVELTREAT 0.25 		SC ONCE A WEEK AFTER BREAKFAST
 TILL NEXT VISIT
5 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
ZEXRIDA 10 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 18/Dec/2026
Tests Suggested For Next Visit : HBA1C-HPLC METHOD,UACR:SPOT SAMPLE,CREATININE,POTASSIUM
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: